Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Development
International trial of two anti-HIV microbicides begins
March 10th, 2005
A large, multisite trial designed to examine the safety and preliminary effectiveness of two candidate topical microbicides to prevent HIV infection has opened to volunteer enrollment. The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), represents a partnership among various research institutions in Africa and the United States. Although no licensed microbicides are available to the public currently, scientists hope these agents - designed to be applied to the surface of the vagina to prevent sexually transmitted infections (STIs) - will one day be a key tool...
Source: Women's Health Weekly (2005-03-10)
|
